CCN2 and adenomyosis: It has been shown that TGFβ1 drives EMT and FMT in adenomyosis development both in animal model and in human [15, 21], although the expression of TGFβ receptor type I to III and CTGF was found to be indifferent at EMJZ in adenomyosis uteri [20].